Marshall Wace’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-21,615
Closed -$53K 3907
2022
Q2
$53K Sell
21,615
-42,565
-66% -$202K ﹤0.01% 3330
2022
Q1
$444K Buy
64,180
+38,878
+154% +$412K ﹤0.01% 2829
2021
Q4
$403K Buy
+25,302
New +$507K ﹤0.01% 2909

Other funds holding RNLX

Marshall Wace's RNLX Position: Q3 2022 in Review

Marshall Wace sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2022, closing a stake of 21,615 shares — an estimated $53K sold.

Marshall Wace first reported a position in RNLX in Q4 2021 and held it in 3 quarters. The position peaked at $444K in Q1 2022. 27 funds tracked by Wall St. Rank hold RNLX as of Q3 2022.

  • Marshall Wace reported no remaining Renalytix plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Marshall Wace sold 21,615 Renalytix plc American Depositary Shares shares in Q3 2022, an estimated $53K.
  • Marshall Wace first reported a position in Renalytix plc American Depositary Shares in Q4 2021 and held it in 3 quarters.
  • Marshall Wace's Renalytix plc American Depositary Shares position peaked at $444K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.